Orna Therapeutics Announces Data Presentation at the 66th ASH Annual Meeting
WATERTOWN, Mass., Nov. 5, 2024 /PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of circular RNA medicines and unprecedented lipid nanoparticle (LNP) delivery